all report title image
  • Published On : Sep 2022
  • Code : CMI5197
  • Industry : Pharmaceutical
  • Pages : 190
  • Formats :

Bruxism is a condition which involves excessive teeth grinding or jaw clenching. This condition can affect adults and children and can occur during the day or at night in sleep. Some people have no symptoms. Others may experience headaches, jaw pain, toothache, or dental problems. Children with this condition generally cure themselves without any medical treatment. For adults, dental splints help protect teeth from damage. Teeth grinding and clenching, increased tooth pain and sensitivity, dull headache, jaw, neck or face pain or soreness, and sleep disruption are some signs of bruxism. In most cases, bruxism does not cause serious complications. But severe bruxism may cause damage to teeth.

Global Bruxism Treatment Market - Impact of the Coronavirus (COVID-19) Pandemic

Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19 as pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 596 million cases and 6.45 million deaths due to coronavirus (COVID-19) were reported till August 26, 2022, across the globe.

Impact of COVID-19 on Demand and Supply of Bruxism Treatment

The COVID-19 pandemic and lockdown in various countries across the globe has impacted the financial status of businesses across all sectors including private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry mainly due to strict lockdown in several regions. The COVID-19 pandemic has affected the economy of various regions across the globe in three main ways; 1) by directly affecting the production and demand; 2) by creating disruptions in distribution channels; and 3) through its financial impact on companies and financial markets. Several countries such as Thailand, Indonesia, and Singapore are facing problems with regards to transportation and distribution of healthcare products.

However, life style changes in adolescent lifestyle during Covid19 lockdown has increased the prevalence of oral parafunctions and bruxism, which is expected to boost the global bruxism treatment market growth over the forecast period. For instance, according to International Journal of Pediatric Dentistry, May 2021, there has been a change in adolescent lifestyle during lockdown with an increase in the prevalence of oral parafunctions and bruxism. In particular, the increase in the use of social networks at night and also in anxiety levels during lockdown were associated with the increase in self-reported bruxism.

Global bruxism treatment market is estimated to be valued at US$ 5,100.9 Mn in 2022, and is expected to exhibit a CAGR of 6.5% over the forecast period (2022-2030).

Figure 1: Global Bruxism Treatment Market Share (%) Analysis, By Disease Type, 2022

Bruxism Treatment  | Coherent Market Insights

Increasing research and development activities in Bruxism are expected to drive growth of the market over the forecast period.

Increasing research and development activities in bruxism are expected to fuel growth of the global bruxism treatment market over the forecast period. For instance, according to a research article published in BMC Oral Health, January 2021, a study was performed on 50 individuals suffering from sleep bruxism in Jordan to examine if sleep bruxism is associated with vitamin D deficiency and low dietary calcium intake. Serum 25-hydroxyvitamin D levels were assessed with Anxiety and depression using the Hospital Anxiety and Depression Scale. Information on dietary calcium intake and headache frequency was self-reported by individuals.  It was found that, in addition to being linked to insufficient calcium intake and vitamin D deficiency, sleep bruxism was also linked to higher levels of anxiety and sadness.

Increase in partnerships, collaborations and agreements between market players is expected to boost the global bruxism treatment market growth over forecast period.

Market players are adopting strategies such as partnerships, which is expected to boost the global bruxism treatment market growth over the forecast period. For instance, in November 2021, Carestream Dental, an industry provider of dental imaging equipment and software, partnered with 3Dmouthguard, a custom made 3D printing mouthgaurd company, to provide protective sports apparel fit for athletes. The two firms had partnered to automate, digitize, and customize mouthguard design and production using Carestream Dental's digital intraoral scanner and 3Dmouthguard's design and printing.

CMI table icon

Bruxism Treatment Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 5,100.9 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2030
Forecast Period 2022 to 2030 CAGR: 6.5% 2030 Value Projection: US$ 8,413.4 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Disease Type: Primary bruxism, Secondary bruxism
  • By Treatment type: Therapeutics (Muscle relaxants (Acetaminophen, etc.), Botox injections, Anti-anxiety drugs (Fluoxetine, Sertraline, etc.)), Devices (Mouth  Guards, NTI-tss and splints)
  • By Patient Type: Children, Adult
  • By End User: Hospitals, Dental Clinics, Homecare Settings, Others (Research Centers, Academic Institutes, etc.)
Companies covered:

Bravrr, Brux Night Guard, Leiner Health Products Inc., Pfizer, Eli Lilly , Patterson Dental Supply Inc., Carestream Dental LLC., Randmark Dental Products LLC, Allergan Aesthetics, S4S (UK) Limited, Viatris Inc. and SprintRay Inc.

Growth Drivers:
  • Increasing research and development activities  
  • Increase in partnerships, collaborations and agreements between market players
  • Number of awareness campaigns by market players
Restraints & Challenges:
  • Increasing side effects of drugs used for bruxism treatment

Restraint- Global Bruxism Treatment Market

Side effects associated with the drugs used for the treatment of Bruxism are expected to hamper growth of the global bruxism treatment market over the forecast period. Side effects of muscle relaxants which are used in bruxism treatment include

  • Nausea
  • Stomach pain
  • Loss of appetite
  • Headache
  • Itching
  • Rash

Global Bruxism Treatment Market – Regional Analysis

On the basis of region, global bruxism treatment market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to be the most lucrative region in the global bruxism treatment market, owing to increasing number of awareness campaigns for bruxism treatment by market players. For instance, on March 9, 2021, Brux Night Guard, a dental health care company based in the U.S., released a statement announcing the start of a new, nationwide advertising campaign in the U.S. for cable networks and local television. The company hopes to reach millions of television viewers who might be experiencing sleep disturbances, migraines, neck and jaw pain, and damaged tooth enamel as a result of teeth clenching and grinding by partnering with ConsumerEXP, an international technology firm providing advertising and marketing packages for television programmers.

Europe is expected to witness significant growth over the forecast period, owing to increasing incidence of stress and anxiety, which causes Bruxism. For instance, according to Health and Safety Executive (HSE) U.K., in 2020–2021, there were 822,000 occurrences of work-related stress, depression, or anxiety, which translates to a prevalence rate of 2,480 per 100,000 employees. In 2020/21 stress, depression or anxiety accounted for 50% of all work-related ill health cases.

Figure 2: Global Bruxism Treatment Market Value (US$ Mn), by Region, 2022

Bruxism Treatment  | Coherent Market Insights

Global Bruxism Treatment Market – Competitive Landscape

Major players operating in the global bruxism treatment market include Bravarr, Brux Night Guard, Leiner Health Products Inc., Pfizer, Eli Lilly, Patterson Dental Supply Inc., Carestream Dental LLC., Randmark Dental Products LLC, Allergan Aesthetics, S4S (UK) Limited, Viatris Inc., and SprintRay Inc.

The term ‘bruxism’ refers to excessive jaw clenching or teeth grinding. Both adults and children can be afflicted by this condition, which can happen at day or night. Some individuals show no symptoms. Others may encounter dental issues, tooth discomfort, jaw pain, or headaches. Kids with this illness frequently get better on their own. Adults who wear dental guards may benefit from tooth damage protection.

Market Dynamics

Increase in partnerships, collaborations and agreements between market players is expected to boost the global bruxism treatment market growth over the forecast period. For instance, in September 2019, GuardLab Inc., a U. S. basedin the sports technology industry that uses 3D scanning and 3D printing to produce the mouthguards in the market, announced a partnership with Bauer Hockey, manufacturer of  hockey equipment, to supply a new line of Bauer APEX and APEX Lite Mouthguards, a GuardLab product.

Increasing number of product approvals and launches are expected to bolster growth of the global bruxism treatment market. For instance, in November 2021, The U.S. Food and Drug Administration (FDA) granted SprintRay Inc. approval to market its NightGuard Flex 3D printing resin as a Class II medical device in the U.S. SprintRay Inc. is a company involved in digital dentistry and 3D printing solutions. The SprintRay NightGuard Flex joins SprintRay's leading lineup of end-to-end dental 3D printing solutions and is intended for the production of orthodontic and dental appliances such as mouthguards, nightguards, and splints.

Increasing research and development activities regarding bruxism are expected to drive growth of market over the forecast period. For instance, according to an article published in Journal of Dentistry and Oral Sciences in May 2022, occlusal splint is used to prevent damage from symptoms of bruxism. An occlusal splint is recommended as the first line of protection against noise bruxism and tooth wear in patients suffering from sleep bruxism. The use of an occlusal splint improves patient comfort by lowering muscular activity. It indicates that using an occlusal splint lessens orofacial pain, masticatory muscle tension, and teeth grinding.

Key features of the study:

  • This report provides an in-depth analysis of global bruxism treatment market, market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains an attractive investment proposition matrix for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global bruxism treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Bravrr, Brux Night Guard, Leiner Health Products Inc., Pfizer, Eli Lilly , Patterson Dental Supply Inc., Carestream Dental LLC., Randmark Dental Products LLC, Allergan Aesthetics, S4S (UK) Limited, Viatris Inc., and SprintRay Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make an informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics.
  • The Global Bruxism Treatment Market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global bruxism treatment market.

Detailed Segmentation:

  • Global Bruxism Treatment Market, By Disease Type:
    • Primary Bruxism
    • Secondary Bruxism
  • Global Bruxism Treatment Market, By Treatment Type:
    • Therapeutics
      • Muscle relaxants (Acetaminophen, etc.)
      • Botox injections
      • Anti-anxiety drugs (Fluoxetine, Sertraline, etc.)
    • Devices
      • Mouth Guards
      • NTI-tss and splints
  • Global Bruxism Treatment Market, By Patient Type:
    • Children
    • Adult
  • Global Bruxism Treatment Market, By End User:
    • Hospitals
    • Dental Clinics
    • Homecare Settings
    • Others (Research Centers, Academic Institutes, etc.)
  • Global Bruxism Treatment Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Bravrr *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Brux Night Guard,
    • Leiner Health Products Inc.,
    • Pfizer
    • Eli Lilly 
    • Patterson Dental Supply Inc.
    • Carestream Dental LLC.
    • Randmark Dental Products LLC
    • Allergan Aesthetics
    • S4S (UK) Limited
    • Viatris Inc.
    • SprintRay Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

Global bruxism treatment market is expected to exhibit a CAGR of 6.5% during the forecast period (2022-2030).
The market is estimated to be valued at US$ 5,100.9 million in 2022.
Bravarr, Brux Night Guard, Leiner Health Products Inc., Pfizer, Eli Lilly , Patterson Dental Supply Inc., Carestream Dental LLC., Randmark Dental Products LLC, Allergan Aesthetics, S4S (UK) Limited, Viatris Inc. and SprintRay Inc.re some of the prominent players operating in the market.
The market is expected to be valued at US$ 8,413.4 million in 2030.
North America is the prominent region in the market.
Increasing research and development activities and increase in partnerships, collaborations and agreements between market players are some of the driving factors, which are expected to drive growth of the market.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo